Thorac Cardiovasc Surg 2002; 50(6): 351-354
DOI: 10.1055/s-2002-35746
Original Cardiovascular
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Mitral Valve Surgery in Patients with Poor Left Ventricular Function

M.  Rothenburger1 , A.  Rukosujew1 , D.  Hammel1 , A.  Dorenkamp1 , C.  Schmidt2 , C.  Schmid1 , T.  Wichter3 , H.  H.  Scheld1
  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Germany
  • 2Department of Anesthesiology and Operative Intensive Care Medicine, University Hospital Muenster, Germany
  • 3Department of Cardiology and Angiology, University Hospital of Muenster, Germany
Further Information

Publication History

Received July 7, 2002

Publication Date:
28 November 2002 (online)

Zoom Image

Abstract

Background: Mitral valve surgery for the correction of secondary mitral valve regurgitation (MR) in cardiomyopathy is associated with a poor outcome. Numerous studies have identified a severe left ventricular dysfunction as an indicator for a poor prognosis. The aim of the study was to asses the follow-up after mitral valve surgery and severe left ventricular dysfunction. Methods: Between 1994 and 2000, 31 patients with mitral regurgitation and a left ventricular ejection fraction of below thirty percent undergoing isolated repair (n = 16) or replacement (n = 15) were investigated. All patients received maximal drug therapy. Twenty-one patients were New York Heart Association (NYHA) class III and 10 were class IV. Follow-up with echocardiography, ECG, and chest x-ray was performed in 87 % of the survivors. The mean duration of follow-up was 39 ± 16 months. Results: The mean duration of ICU and hospital stay was 3.6 ± 2.1 days and 8.1 ± 5.4 days, respectively. The 1-, 2-, and 5-year survival rates were 91 %, 84 %, and 77 %, respectively. NYHA class improved from 3.3 ± 0.8 to 2.1 ± 0.7 at follow-up (p < 0.01). The ejection fraction improved from 23.1 ± 6.6 % to 36 ± 6.8 % at follow-up (p < 0.02). Freedom from readmission for heart failure was 85 %, 79 %, and 68 % at 1-, 2-, and 5 years, respectively. Conclusions: Mitral valve surgery improves left ventricular function and reduces heart failure severity in patients with MR and cardiomyopathy. High-risk mitral valve surgery may be an alternative to heart transplantation in selected patients.